Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke
- 31 May 2013
- journal article
- research article
- Published by Wiley in Emergencias
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Endovascular Therapy after Intravenous t-PA versus t-PA Alone for StrokeThe New England Journal of Medicine, 2013
- Endovascular Treatment for Acute Ischemic StrokeThe New England Journal of Medicine, 2013
- Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisThe Lancet, 2012
- Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke (ICTuS-L)Stroke, 2010
- Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical PracticeStroke, 2010
- Phase IIB/III Trial of Tenecteplase in Acute Ischemic StrokeStroke, 2010
- Randomized, Placebo-Controlled, Dose-Ranging Clinical Trial of Intravenous Microplasmin in Patients With Acute Ischemic StrokeStroke, 2009
- Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled studyThe Lancet Neurology, 2009
- Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of OnsetStroke, 2006
- Therapy of Basilar Artery OcclusionStroke, 2006